STUDIES ON PREVENTION OF EXPERIMENTAL TUBERCULOSIS WITH ISONIAZID .2. EFFECTS OF DIFFERENT DOSAGE REGIMENS

被引:0
|
作者
PALMER, CE
FEREBEE, SH
HOPWOOD, L
机构
来源
AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES | 1956年 / 74卷 / 06期
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:917 / 939
页数:23
相关论文
共 50 条
  • [1] Tuberculosis: Relevance of Isoniazid Dosage in Prevention of Liver Side Effects
    Negri, Lucie
    Le Grusse, Jean
    Seraissol, Patrick
    Lavit, Michel
    Houin, Georges
    Gandia, Peggy
    THERAPIE, 2014, 69 (06): : 509 - 516
  • [2] PREVENTION OF EXPERIMENTAL TUBERCULOSIS WITH ISONIAZID
    FEREBEE, SH
    PALMER, CE
    AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES, 1956, 73 (01): : 1 - 18
  • [3] INCREASED EFFECT WITH INCREASED DOSAGE OF ISONIAZID IN EXPERIMENTAL TUBERCULOSIS
    NOUFFLARD, H
    BERTEAUX, S
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1960, 82 (04): : 561 - 563
  • [5] Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
    Rosenthal, Ian M.
    Zhang, Ming
    Almeida, Deepak
    Grosset, Jacques H.
    Nuermberger, Eric L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (09) : 989 - 993
  • [6] THE ANTI-TUBERCULOSIS EFFECTS OF THE GLUCURONOSIDE OF ISONIAZID - CLINICAL AND EXPERIMENTAL STUDIES
    SUDHOF, H
    KROGER, E
    KELLNER, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1957, 82 (18) : 722 - +
  • [7] DOSAGE REGIMENS OF ANTIARRHYTHMICS .2. APPLICATIONS
    LEVY, RH
    SMITH, GH
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1973, 30 (06): : 494 - 498
  • [8] ADVERSE-EFFECTS OF 2 RIFAMPICIN DOSAGE REGIMENS FOR THE PREVENTION OF MENINGOCOCCAL INFECTION
    BAND, JD
    FRASER, DW
    LANCET, 1984, 1 (8368): : 101 - 102
  • [9] Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
    Requena-Mendez, Ana
    Davies, Geraint
    Waterhouse, David
    Ardrey, Alison
    Jave, Oswaldo
    Llanet Lopez-Romero, Sonia
    Ward, Stephen A.
    Moore, David A. J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7164 - 7170